Scientists test First-Ever shot against deadly Brain-Swelling virus
NCT ID NCT05398796
Summary
This was the first study in people to test an experimental mRNA vaccine designed to prevent Nipah virus infection. The trial enrolled 40 healthy adults to check if the vaccine was safe and if it triggered an immune response. Participants received two shots a month apart, and researchers monitored them for over a year to track side effects and measure antibody levels in their blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NIPAH VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.